Prospective, randomized, multi-center feasibility trial of rhPDGF-BB versus autologous bone graft in a foot and ankle fusion model

Foot and Ankle International

Volumn 32, Issue 4, 2011, Pages 344-354

  DiGiovanni, Christopher W ^a   Baumhauer, Judith ^a   Lin, Sheldon S ^a   Berberian, Wayne S ^a   Flemister, Adolph S ^a   Enna, Matthew J ^a   Evangelista, Peter ^a   Newman, June ^a  

^a NONE

Author keywords

Ankle and hindfoot fusion; Autologous bone graft; Biosynthetic bone graft substitute; Recombinant platelet derived growth factor

Indexed keywords

CALCIUM PHOSPHATE; NEUTRALIZING ANTIBODY; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB;

ADULT; ANKLE; ANKLE AND HINDFOOT FUSION; ANKLE ARTHRODESIS; ANTIBODY SCREENING; ARTHRITIS; ARTICLE; BONE GRAFT; BONE PROSTHESIS; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEVICE SAFETY; DRUG EFFICACY; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FOOT; FOOT RADIOGRAPHY; FOOT SURGERY; HUMAN; MALE; MEDICAL INSTRUMENTATION; MULTICENTER STUDY; OPERATION DURATION; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTTRAUMATIC ARTHROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WEIGHT BEARING; WOUND HEALING;

ADULT; ANGIOGENESIS INDUCING AGENTS; ANKLE; BONE REGENERATION; BONE TRANSPLANTATION; FEASIBILITY STUDIES; FEMALE; FOOT; HUMANS; PLATELET-DERIVED GROWTH FACTOR; PROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 79954486077     PISSN: 10711007     EISSN: None     Source Type: Journal    
DOI: 10.3113/FAI.2011.0344     Document Type: Article

References (28)

1. Al-Zube, L; Breitbart, EA; O'Connor, JP; et al.: Recombinant Human Platelet-Derived Growth Factor BB (rhPDGF-BB) and Beta-Tricalcium Phosphate/Collagen Matrix Enhance Fracture Healing in a Diabetic Rat Model. J Ortho Res. 27(8):1074-81, 2009. http://dx.doi.org/10.1002/jor.20842
2. Burkus, JK; Gornet, MF; Dickman, CA; Zdeblick, TA: Anterior Lumbar Interbody Fusion Using rhBMP-2 with Tapered Interbody Cages. J Spinal Disord Tech. 15:337-349, 2002.
3. Coughlin, MJ; Grimes, JS; Traughber, PD; Jones, CP: Comparison of Radiographs and CT Scans in the Prospective Evaluation of the Fusion of Hindfoot Arthrodesis. Foot and Ankle Int. 27(10):780-787, 2006.
4. Daniels, T; DiGiovanni, C; Lau, J; Wing, K; Younger, A: Prospective Clinical Pilot Trial in a Single Cohort Group of rhPDGF in Foot Arthrodeses. Foot Ankle Int. 31(6):473-479, 2010. http://dx.doi.org/10.3113/FAI.2010.0473
5. Dorsey, ML: Correlation of Arthrodesis Stability with Degree of Joint Fusion on MDCT. Am J Rad. 192:496-499, 2009.
6. Easley, M; Trnka, H; Schon, L; Myerson, M: Isolated Subtalar Arthrodesis. JBJS Am. 82-A(5): 613-624, 2000.
7. Foot and Ankle. In: The OrthoFact Book™: U.S. 5th Edition. Chagrin Falls, OH: Knowledge Enterprises; 2005 April.
8. Frey, C; Halikus, N; Vu-Rose, T; Ebramzadeh, E: A Review of Ankle Arthrodesis: Predisposing Factors to Nonunion. Foot Ankle Int. 5(11):581-584, 1994.
9. Friedlaender, GE; Perry, CR; Cole, DJ; et al.: Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions. JBJS Am. 83 Suppl 1:S151-158, 2001.
10. Gazdag, A; Lane, J; Glaser, D; Forster, R: Alternatives to Autogenous Bone Graft: Efficacy and Indications. JAAOS. 3(1):1-8, 1995.
11. Govender, S; Csimma, C; Genant, HK; et al.: BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients. JBJS Am. 84:2123-2134, 2002.
12. Hollinger, J; Onikepe, A; MacKrell, J; et al.: Accelerated Fracture Healing in the Geriatric, Osteoporotic Rat with Recombinant Human Platelet-Derived Growth Factor-BB and an Injectable Beta-Tricalcium Phosphate/Collagen Matrix. Journal of Orthopaedic Research 26(1):83-90, 2008. http://dx.doi.org/10.1002/jor.20453
13. Howell, TH; Fiorellini, JP; Paquette, DW; et al.: A Phase I/II Clinical Trial to Evaluate a Combination of Recombinant Human Platelet-derived Growth Factor-BB and Recombinant Human Insulin-like Growth Factor-I in Subjects with Periodontal Disease. J Periodontol. 68:1186-1193, 1997.
14. Johnsson, R; Stromqvist, B; Aspenberg, P: Randomized Radiostereometric Study Comparing Osteogenic Protein-1 (BMP-7) and Autograft Bone in Human Non- Instrumented Posterolateral Lumbar Fusion. Spine. 27:2654-2661, 2002. http://dx.doi.org/10.1097/00007632-200212010-00004
15. Kohler, N; Lipton, A: Platelets as a Source of Fibroblast Growth-Promoting Activity. Exp. Cell Res. 87:197-301, 1974. http://dx.doi.org/ 10.1016/0014-4827(74)90484-4
16. Lynch, SE; Williams, RC; Polson, A; et al.: A Combination of Platelet-Derived Growth Factor and Insulin-like Growth Factor Enhances Periodontal Regeneration. J Clin Periodontol. 16:545-554, 1989. http://dx.doi.org/10.1111/j.1600-051X.1989.tb02334.x
17. Moore, DC; Ehrlich, MG; McAllister, SC; et al.: Recombinant Human Platelet-Derived Growth Factor-BB Augmentation of New-Bone Formation in a Rat Model of Distraction Osteogenesis. JBJS Am. 91:1973-1984, 2009.
18. Nevins, M; Giannobile, WV; McGuire, MK; et al.: Platelet-Derived Growth Factor Stimulates Bone Fill and Rate of Attachment Level Gain: Results of a Large Multicenter Randomized Controlled Trial. J Periodontol. 76(12):2205-2215, 2005. http://dx.doi.org/10.1902/jop.2005.76.12.2205
19. Praemer, AF; Furner, S; Rice, DP: Musculoskeletal Conditions in the United States. American Academy of Orthopaedic Surgeons. 1999:85-124.
20. Ranly, DM; Lohmann, CH; Andreacchio, D; Boyan, BD; Schwartz, Z: Platelet-Rich Plasma Inhibits Demineralized Bone Matrix-Induced Bone Formation in Nude Mice. JBJS Am. 89(1):139-147, 2007.
21. Ranly, DM; McMillan, J; Keller, T; et al.: Platelet-Derived Growth Factor Inhibits Demineralized Bone Matrix-Induced Intramuscular Cartilage and Bone Formation. A Study of Immunocompromised Mice. JBJS Am. 87(9):2052-2064, 2005.
22. Ross, R; Glomset, J; Kariya, B; Harker, L: A Platelet-Dependent Serum Factor that Stimulates the Proliferation of Arterial Smooth Muscle Cells in Vitro. Proc. Nat. Acad. Sci. 71:1207-1210, 1974. http://dx.doi.org/10.1073/pnas. 71.4.1207
23. Ross, R; Vogel, A: The Platelet-Derived Growth Factor. Cell. 14:203-210, 1978 June.
24. Ross, R; Raines, E; Bowen-Pope, D: The Biology of Platelet-Derived Growth Factor. Cell. 46:155-169, 1986 July.
25. St. John, TA; Vaccaro, AR; Sah, AP; et al.: Physical and Monetary Costs Associated with Autogenous Bone Graft Harvesting. Am J Ortho. 18-23, 2003 Jan.
26. Summers, BN, Eisenstein, SM: Donor Site Pain from the Ilium. JBJS Br. 71:677-680, 1989.
27. Younger, EM; Chapman, MW: Morbidity at Bone Graft Donor Sites. J Orthop Trauma. 3:192-195, 1989. http://dx.doi.org/10.1097/00005131-198909000-00002
28. Zelen, M: The Randomization and Stratification of Patients to Clinical Trials. J Chronic Disease. 27(7-8):365-375, 1974. http://dx.doi.org/10.1016/ 0021-9681(74)90015-0